Over the five years to 2015, the Global Pharmaceuticals and Medicine Manufacturing industry experienced moderate growth. Underpinning this growth has been rising demand for healthcare and medications worldwide, especially from emerging economies. Higher healthcare standards and greater emphasis on illness prevention have given pharmaceuticals a higher significance among consumers, driving sales over the period. However, the consequences of the credit crisis and subsequent austerity measures implemented by various governments worldwide translated into cuts in healthcare funding. Nonetheless, the industry will continue to grow ascetically over the next five years, with revenue forecast to increase due to the world's aging population boosting healthcare demand and expanding emerging markets.
This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based (or ethical) products and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.